Report Library
View More
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
2025 American Academy of Neurology ...
May 22, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
2025 American Academy of Dermatolog...
June 3, 2025
Datamonitor Healthcare I&I: Irritab...
June 3, 2025
2025 Biomedtracker Datamonitor Heal...
June 1, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
2025 Biomedtracker Datamonitor Hea...
May 23, 2025
2025 American Academy of Neurology ...
May 22, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
2025 American Academy of Dermatolog...
June 3, 2025
Datamonitor Healthcare I&I: Irritab...
June 3, 2025
2025 Biomedtracker Datamonitor Heal...
June 1, 2025
Datamonitor Healthcare Oncology: NH...
May 30, 2025
Datamonitor Healthcare Oncology: My...
May 29, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
HIV Pre-Exposure Prophylaxis (HIV P...
May 27, 2025
Datamonitor Healthcare Oncology: Ho...
May 27, 2025
Datamonitor Healthcare Other: Uteri...
May 27, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/3/25 | GSK (GSK) | Zejula for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Johnson & Johnson (JNJ) | Akeega for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Pfizer (PFE) | Braftovi for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Bristol (BMY) | Opdualag IV for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/25 | Pfizer (PFE) | Mektovi for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/20/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/22/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/02/2025 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |